The drugmaker could decide to spin off the business via an IPO if the offers are not deemed sufficiently attractive. A few weeks ago, rumors had been circulating about a slightly higher valuation target of around $20 billion.
PAI is reportedly seeking to attract British Columbia Investment Manageme…
© MarketScreener.com 2024
PAI is reportedly seeking to attract British Columbia Investment Manageme…
© MarketScreener.com 2024